1 The $262B Problem Nobody Is Fixing Fast Enough
$262 billion in claims denied every year. That is the headline number. Here is the one that should make every CFO stop cold: providers spend $19.7 billion annually just fighting those denials, covering appeals, chart reviews, and administrative overhead. You are not just losing revenue. You are paying a fortune to try to get it back.
The cost of each individual fight is $43.84. That is what the American Hospital Association says providers spend, on average, to appeal a single denied claim. Every denial. Every time. Now do the math on your denial volume.
15% of claims submitted to private payers are initially denied. Medicare Advantage is worse, at 15.7% according to KFF's 2023 analysis. HFMA data shows the overall initial denial rate hit nearly 12% in 2024 and has held there. This is not a temporary spike. It is the new floor.
The asymmetry is deliberate. Payers are deploying AI to deny claims faster, flag medical necessity more aggressively, and automate prior auth rejections at scale. Your team is still pulling charts manually, navigating payer portals one tab at a time, drafting appeal letters from scratch. The gap between how fast denials arrive and how fast your team can respond is widening every quarter.
McKinsey projects that agentic AI could cut cost-to-collect by 30 to 60%. That is not a rounding error. That is the structural fix to a structural problem. The money is there. The question is whether you can recover it without spending it all on the recovery.
2 What Is Agentic AI? (And Why It Is Different From Regular AI)
Most AI tools in healthcare RCM today do one thing: they predict or they generate. A machine learning model scores a claim's denial risk. A generative AI tool drafts a letter. Useful, but passive. Someone still has to act on the output.
Agentic AI is different. An AI agent is designed to pursue a goal across multiple steps, making decisions, calling tools, self-correcting when something does not work, and completing the task autonomously.
RPA bots follow rigid rules
Change a payer's portal layout and the bot breaks. RPA was a meaningful step forward in 2015. It is a bottleneck in 2026.
Traditional ML predicts outcomes
It tells you a claim will likely be denied. It does not do anything about it. Data without action is just a prettier report.
Generative AI produces content on request
It can draft an appeal letter if you ask it to. It will not go find the denial, read the EOB, and structure a payer-specific response on its own.
Agentic AI does all of the above, in sequence
It reads the denial. It identifies the reason code. It pulls the relevant clinical documentation. It drafts a payer-specific appeal. The analyst reviews and approves. That is not a chatbot. That is an autonomous denial recovery engine with a human in the loop.
3 How the DataRovers RCM Agent Works
Revenue cycle automation has always had three hard problems: knowing which denials to chase, knowing how to fight them, and actually doing the work fast enough to matter. The DataRovers RCM Agent is built to solve all three through a queue-based orchestrator model that puts the analyst in control without burying them in manual work.
4 The 3 Skills That Make the RCM Agent Work
The RCM Agent does not try to do everything. It does three things exceptionally well, each one a Skill that activates the moment an analyst clicks the button on a claim.
The RCM Agent reads the denied claim in full. It analyzes the denial reason code and the Explanation of Benefits. It retrieves the relevant clinical documentation. Then it autonomously generates a complete, payer-specific appeal letter, ready for submission.
Not a template with blanks to fill in. A finished document, calibrated to that payer's known requirements and the specific denial reason code cited. What used to take 45 to 90 minutes now takes minutes.
When a claim is denied due to prior authorization issues, the RCM Agent assesses the denial in full context. It reviews the prior auth requirements for that specific payer, evaluates what was submitted versus what was actually required, and delivers a structured recommendation on the best path to resolution.
That recommendation might be: file an appeal. Or: request a peer-to-peer review. Or: resubmit with additional documentation. The analyst gets a clear, evidence-backed recommendation instead of starting from scratch.
For any denial type, the RCM Agent generates a step-by-step action plan for the analyst. Exactly what needs to be done. In what order. To resolve the denial within the existing workflow.
No guessing. No tribal knowledge required. No senior analyst needed to explain the process to a newer team member. Particularly powerful for teams dealing with high turnover or staff shortages.
5 Agentic AI vs. Traditional RCM Automation: The Honest Comparison
| Capability | RPA Bots | Traditional ML | Agentic AI (DataRovers) |
|---|---|---|---|
| Decision-making | Rule-based only | Prediction only | Multi-step reasoning |
| Adaptability | Breaks on change | Retrains slowly | Self-corrects in real time |
| Multi-step tasks | No | No | Yes |
| Denial handling | Routing only | Scoring only | Button-click activation, analyst reviews output |
| Appeal generation | No | No | Payer-specific, human-in-the-loop |
| ROI speed | 6 to 18 months | 6 to 12 months | Under 90 days |
RPA was a meaningful step forward in 2015. It is a bottleneck in 2026. Traditional ML gave RCM teams better data, but data without action is just a prettier report. Agentic AI closes the loop. It is the difference between a system that tells you what is wrong and a system that hands the analyst a finished appeal letter and a clear action plan.
6 What Results Can You Actually Expect?
DataRovers benchmarks across health system deployments, not projections but outcomes from real post-submission recovery workflows:
The pattern seen consistently: teams that refuse to accept "that is just how it is" are the ones seeing these numbers. The ones still running denials through spreadsheets and shared inboxes are the ones watching their denial write-off rate climb every quarter.
HFMA data shows initial claim denial rates hit nearly 12% in 2024 and have held there into 2025. That is not a temporary spike. That is the new baseline, and it is getting worse as payers deploy their own AI to deny claims faster. The battle of the bots is real. The only question is whether your side is armed.
For a health system with $6 billion in patient revenue, even a 1 to 2 percentage-point improvement in cost-to-collect translates to $60 to $120 million in annual savings, per McKinsey's research on agentic AI in healthcare.
7 How to Evaluate an Agentic AI Platform for RCM
Not every vendor calling their product "agentic" is telling you the truth. Here are five questions that cut through the noise:
Does it act, or does it just predict?
If the platform's output is a dashboard or a score, it is not agentic. Ask specifically: does it generate a complete, payer-specific appeal letter when an analyst clicks a button? If the answer is "it helps your team do that," it is a tool, not an agent.
Is the human in the loop by design?
True agentic AI for RCM does not mean fully autonomous submission without review. It means the agent does the analytical and drafting work; the human reviews and approves. Ask how the platform handles the handoff between agent output and human decision.
Can it generate payer-specific appeals?
Generic appeal templates do not win. Ask whether the system knows the difference between a Blue Cross denial and a UnitedHealthcare denial, and whether it adjusts the appeal language accordingly.
What is the integration timeline?
AI agents RCM teams can actually use need to connect to your EHR, PM system, and payer portals. Ask for a realistic go-live timeline and what the implementation lift looks like on your side.
What is the measurable ROI benchmark?
Any serious vendor should be able to give you a specific number: appeal win rate, days to ROI, average recovery. If the answer is "it depends" or "results vary," push harder. Vague answers mean they do not have the data. The DataRovers team answers all five with specific, auditable numbers.
Stop Sending a Manual Knife to an AI Fight
Start your 90-day pilot with DataRovers Denials 360 and start seeing results from day one.
Schedule a Demo8 Frequently Asked Questions
Agentic AI in healthcare revenue cycle management refers to autonomous AI systems that pursue specific goals, like recovering denied claims, across multiple steps, without requiring a human to trigger each action manually. In practice, an analyst clicks a button on a claim, and the agent activates: it reads the denial, reasons about the best response, and delivers a finished output, an appeal letter, a structured recommendation, or a step-by-step action plan. The human reviews and approves. The agent did the work.
Traditional RCM automation, including RPA bots and rules-based workflow tools, follows fixed rules and breaks when conditions change. Traditional machine learning predicts denial risk but does not act on it. Agentic AI combines reasoning and action in a single autonomous workflow. The DataRovers RCM Agent can read an EOB, identify a denial reason code, retrieve clinical documentation, and generate a complete payer-specific appeal letter, all triggered by one analyst click, with the human reviewing the output before submission.
Yes, with the analyst in the loop. The DataRovers RCM Agent activates on a button click, runs the appropriate Skill autonomously (Appeals, Prior Auth Denial Assessment, or Action Plan), and delivers its output back to the analyst for review and approval. The agent handles the analytical and drafting work; the human makes the final call. This human-in-the-loop model is what makes it both powerful and safe for healthcare workflows.
The DataRovers RCM Agent is an AI orchestrator that sits on specified claims queues. When an analyst clicks a button on a claim, it activates one of three Skills: the Appeals Skill, which reads the denial, analyzes the reason code and EOB, retrieves clinical documentation, and generates a complete payer-specific appeal letter; the Prior Auth Denial Assessment Skill, which evaluates what was submitted versus what was required and delivers a structured recommendation; and the Action Plan Skill, which generates a step-by-step executable roadmap for resolving the denial within the analyst's workflow.
Health systems deploying the DataRovers RCM Agent report ROI in under 90 days. This is significantly faster than traditional RPA implementations, which typically take 6 to 18 months to show measurable returns. The speed comes from the platform's ability to immediately begin working the existing denial backlog. The agent starts generating appeal letters and action plans from day one, without extended configuration or training periods.
Yes, when properly implemented. HIPAA compliance for agentic AI requires a signed Business Associate Agreement (BAA) with every vendor whose system touches Protected Health Information (PHI), encryption in transit and at rest, strict access controls, immutable audit logging across the full agent workflow, and a contractual prohibition on using PHI for model training. Any agentic AI platform operating in healthcare RCM should provide documentation of all these controls before you allow it to touch patient or claims data.
The RCM Agent is built for post-submission denial recovery and covers the denial types where agentic AI delivers the clearest ROI: medical necessity denials via the Appeals Skill, prior authorization denials via the Prior Auth Denial Assessment Skill, and complex multi-step denials of any type via the Action Plan Skill. The agent is configured to sit on specific queue types so it is always working the denial category it was built for.
The RCM Agent orchestrator is configured once to sit on specific claims queues, for example a prior auth denial queue or an appeals backlog queue. The analyst opens a claim in that queue and clicks a button. The agent activates, identifies the denial type, selects the appropriate Skill, runs the full analytical workflow autonomously, and delivers its output back to the analyst. The analyst reviews, approves, and moves on. No manual research. No starting from a blank page. No tribal knowledge required.